You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 12 No. 1, January 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Studies on Neuraminic Acid

In the Cerebrospinal Fluid in Schizophrenia

JACK PETER GREEN, PhD, MD; ROGER P. ATWOOD, MD; DANIEL X. FREEDMAN, MD

Arch Gen Psychiatry. 1965;12(1):90-95.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Derivatives of neuraminic acid1,2 (or sialic acids) are widely distributed in tissues. In brain, neuraminic acid is found in especially high concentration in gray matter,3,4 the pineal body,5 and the hypophysis.6 As a component of gangliosides, N-acetylneuraminic acid accumulates in the brains of patients with infantile amaurotic familial idiocy.7,8 The function of neuraminic acid is not known, but it has been implicated in the binding of biogenic amines,9,10 and in brain its concentration appears to fall after treatment with reserpine and chlorpromazine.44 Blood levels of neuraminic acid are altered in many diseases.11 In the cerebrospinal fluid (CSF), changes have been noted in parkinsonism12 and in schizophrenia.

Bogoch13 first reported that CSF of schizophrenic patients contains abnormally low levels of neuraminic acid. This conclusion was based on values obtained by measuring the chromophore . . . [Full Text PDF of this Article]


Author Affiliations

NEW HAVEN, CONN

From the Departments of Pharmacology and Psychiatry, Yale University School of Medicine. Some of the results were taken from a thesis submitted by Dr. Atwood in partial fulfillment of the requirements for the degree of Doctor of Medicine from Yale University.


Footnotes

Submitted for publication June 3, 1964.

This work was supported by grants from the National Institute of General Medical Sciences, Public Health Service (GM-10313-02) and the American Heart Association (60-G-71). Dr. Green and Dr. Freedman are recipients of Career Development Awards of the National Institute of General Medical Sciences (2K3-GM-2459) and the National Institute of Mental Health (K-MH18566), respectively.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.